OpportunityTitle: Targeted Radiochemistry and Associated Technology Development for Integrated Nuclear Medicine Research and Training with Human Application: A Joint Research Funding Opportunity Announcement NIH, DOE
AdditionalInformationOnEligibility: All types of entities are eligible to apply, except other Federal agencies, Federally Funded Research and Development Center (FFRDC) Contractors, and nonprofit organizations described in section 501(c)(4) of the Internal Revenue Code of 1986 that engaged in lobbying activities after December 31, 1995. Synergistic collaborations with researchers in Federal Laboratories and Federally Funded Research and Development Centers (FFRDCs), including the DOE National Laboratories are permitted. Collaborations should be limited to filling critical voids in expertise and can represent no more than 50 percent of the total budget.
Description: The U.S. Department of Energy&apos;s Office of Science, Office of Biological and Environmental Research (OBER), and the National Institutes of Health (NIH), National Institute of Biomedical Imaging and Bioengineering (NIBIB), hereby announce their interest in receiving applications for potential funding of Translational Biomarkers Development to serve two important goals: 1. Develop clinically relevant radionuclide imaging biomarkers to individualize and optimize medical care through new, improved diagnostic and theranostic approaches, and 2. Enhancement of training opportunities of young scientists and clinicians in translational nuclear medicine. Applicants must have access to existing advanced facilities and an interdisciplinary collaborative team of clinicians specialized in human disease- or disorder-specific nuclear medicine imaging techniques as well as radiochemists, synthetic chemists, and/or biochemists with the ability to support a robust research-training environment. Institutional settings should offer broad ranging research collaborations between clinical physicians and basic and translational research scientists. In addition, research applicants should have easy access to advanced nuclear medicine imaging facilities, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT), and radiochemistry laboratories for radiotracer synthesis, validation and quality control.
GrantorContactEmailDescription: kim.laing@science.doe.gov
GrantorContactText: Kimberlie J. Laing, Grant Management Specialist, 301-903-3026&lt;br/&gt;kim.laing@science.doe.gov&lt;br/&gt;Prem C. Srivastava, Program Manager, 301-903-4071&lt;br/&gt;prem.srivastava@science.doe.gov&lt;br/&gt;